These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7831677)

  • 1. In vitro model to test the thrombogenicity of coronary stents.
    Beythien C; Terres W; Hamm CW
    Thromb Res; 1994 Sep; 75(6):581-90. PubMed ID: 7831677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the thrombogenicity of stainless steel and tantalum coronary stents.
    Scott NA; Robinson KA; Nunes GL; Thomas CN; Viel K; King SB; Harker LA; Rowland SM; Juman I; Cipolla GD
    Am Heart J; 1995 May; 129(5):866-72. PubMed ID: 7732974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restenosis following placement of an intracoronary heparin treated tantulum stent in the hyperlipidemic miniature swine model.
    Jenkins JS; Webel R; Laughlin MH; Rowland SM; Yoklavich MF; Amann JF; Branson K; Myers PR
    J Invasive Cardiol; 1995; 7(6):173-82. PubMed ID: 10155102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet and fibrin deposition on coronary stents in minipigs: effect of hirudin versus heparin.
    Buchwald AB; Sandrock D; Unterberg C; Ebbecke M; Nebendahl K; Lüders S; Munz DL; Wiegand V
    J Am Coll Cardiol; 1993 Jan; 21(1):249-54. PubMed ID: 7678021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis.
    Makkar RR; Litvack F; Eigler NL; Nakamura M; Ivey PA; Forrester JS; Shah PK; Jordan RE; Kaul S
    Circulation; 1997 Feb; 95(4):1015-21. PubMed ID: 9054765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of heparin coating of coronary stents and ex vivo efficacy of different doses of acetylsalicylic acid and ticlopidine in a pulsed floating model of recirculating human plasma.
    Brockmann MA; Gutensohn K; Bau J; Kuehnl P; Meinertz T; Nienaber C; Beythien C
    Platelets; 2002 Dec; 13(8):443-9. PubMed ID: 12487777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Course of thrombin activation markers in patients implanted with Palmaz-Schatz stents: first experiences with a post-interventional anticoagulation regimen.
    Haushofer A; Halbmayer WM; Dittel M; Prachar H; Mlczoch J; Fischer M
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):697-706. PubMed ID: 7865675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation.
    Monnink SH; van Boven AJ; Peels HO; Tigchelaar I; de Kam PJ; Crijns HJ; van Oeveren W
    J Investig Med; 1999 Jul; 47(6):304-10. PubMed ID: 10431485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries.
    Hårdhammar PA; van Beusekom HM; Emanuelsson HU; Hofma SH; Albertsson PA; Verdouw PD; Boersma E; Serruys PW; van der Giessen WJ
    Circulation; 1996 Feb; 93(3):423-30. PubMed ID: 8565158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting.
    Neumann FJ; Gawaz M; Ott I; May A; Mössmer G; Schömig A
    J Am Coll Cardiol; 1996 Jan; 27(1):15-21. PubMed ID: 8522689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
    Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P
    Lancet; 1989 Jul; 2(8653):1-7. PubMed ID: 2567792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregation and the risk of stent thrombosis or bleeding in elective percutaneous coronary intervention patients.
    Kukula K; Klopotowski M; Kunicki P; Jamiolkowski J; Debski A; Bekta P; Chmielak Z; Witkowski A
    Blood Coagul Fibrinolysis; 2017 Jul; 28(5):383-388. PubMed ID: 28009648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation and coronary stent implantation. Effect of antithrombotic therapy.
    Gawaz M; Neumann FJ; Ott I; May A; Schömig A
    Circulation; 1996 Aug; 94(3):279-85. PubMed ID: 8759067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
    Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute thrombogenicity of arterial prostheses exposed to reduced blood flow in dogs: effects of heparin, aspirin, and prostacyclin.
    Merhi Y; Bernier J; Marois Y; Guidoin R
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):1-5. PubMed ID: 7564348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.
    Turner NA; Moake JL; Kamat SG; Schafer AI; Kleiman NS; Jordan R; McIntire LV
    Circulation; 1995 Mar; 91(5):1354-62. PubMed ID: 7867173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemocompatibility of polymer-coated stainless steel stents as compared to uncoated stents.
    Mrowietz C; Franke RP; Seyfert UT; Park JW; Jung F
    Clin Hemorheol Microcirc; 2005; 32(2):89-103. PubMed ID: 15764818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid in vitro biocompatibility assay of endovascular stents by flow cytometry using platelet activation and platelet-leukocyte aggregation.
    Tárnok A; Mahnke A; Müller M; Zotz RJ
    Cytometry; 1999 Feb; 38(1):30-9. PubMed ID: 10088974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized comparison of early and late results of a carbonized stent versus a high-grade stainless steel stent of identical design: the PREVENT Trial [corrected].
    Sick PB; Brosteanu O; Ulrich M; Thiele H; Niebauer J; Busch I; Schuler G
    Am Heart J; 2005 Apr; 149(4):681-8. PubMed ID: 15990753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of coronary stent-induced alterations of platelet antigens in an in vitro model.
    Gutensohn K; Beythien C; Bau J; Meinertz T; Kuehnl P
    Thromb Res; 1997 Apr; 86(1):49-56. PubMed ID: 9172286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.